Chronic inflammatory diseases such as rheumatoid arthritis are driven in part by resident stromal cells: activated fibroblasts sustain inflammation and can mediate subsequent cartilage and bone destruction. Understanding how an inflammatory fibroblast acquires tissue‑destructive properties is critical to separating inflammation from irreversible structural damage and to identifying potential therapeutic targets.
The authors of the preprint report that the transcription factor ARID5B mediates a shift in pathologic fibroblast behavior from primarily inflammatory functions toward migratory and invasive phenotypes associated with tissue erosion.
According to the study abstract, ARID5B is upregulated in inflammatory fibroblasts and drives a phenotypic change characterized by increased migration and invasion. On a gene‑expression level, ARID5B localizes to loci associated with both inflammatory responses and invasive behavior. The net transcriptional outcome attributed to ARID5B activity is a coordinated repression of pro‑inflammatory genes alongside enhanced expression of pro‑invasive genes, producing an inflammatory‑to‑destructive shift in fibroblast function.
These observations are presented as a mechanistic link between fibroblast‑driven tissue inflammation and the later development of erosive pathology that damages cartilage and bone.
The authors describe ARID5B as recruiting or binding histone editors, and they report localization of ARID5B to both inflammatory and invasive gene loci. Through these interactions, ARID5B is proposed to effect epigenetic repression of inflammatory gene programs while promoting chromatin states that support invasive gene expression. The abstract frames this activity as a transcriptional and epigenetic remodeling that redirects fibroblast outputs from inflammation toward tissue‑destructive behavior.
The preprint emphasizes ARID5B’s role as a regulatory node that both silences and activates distinct gene sets via chromatin‑associated mechanisms; exact biochemical partners, histone modifications, and locus‑level data are described in the full manuscript rather than in the abstract.
The authors report that fibroblast‑specific overexpression of ARID5B in vivo produced an inflammatory‑to‑erosive shift in arthritis pathology. This finding is presented as functional evidence that ARID5B is sufficient, in the stromal compartment, to bias disease manifestations toward tissue destruction.
The abstract does not provide specific experimental details such as the animal model used, timing, extent of overexpression, quantitative measures of erosion, or sample sizes; those details are located in the full preprint and supplementary material.
By identifying ARID5B as a factor that couples inflammatory activation with acquisition of invasive, tissue‑destructive properties in fibroblasts, the study suggests a potential strategy to dissociate chronic inflammation from irreversible structural damage. Targeting ARID5B itself, its interactions with histone editors, or downstream invasive gene programs could, in principle, reduce fibroblast‑mediated erosion while preserving or modulating inflammatory signaling.
The authors frame ARID5B as a “maladaptive brake” on inflammatory activation that paradoxically confers pathologic invasiveness; this positions ARID5B and its epigenetic effects as candidate targets for interventions that aim to limit erosion in inflammatory arthritides.
This report is a preprint posted on bioRxiv and has not been peer reviewed; conclusions should be interpreted in that context and verified against the full manuscript and subsequent peer‑reviewed publication. The abstract does not include experimental detail on methods, quantitative results, or limitations; those are available in the full text.
The authors disclose a competing interest: M.B.B. serves on scientific advisory boards and has consulting and founder roles as described in the manuscript. Funding sources declared include several NIH institutes and the Rheumatology Research Foundation. For precise methodological, quantitative, and supporting data, readers should consult the complete preprint and supplementary materials.
Note: all statements in this summary are drawn from the preprint abstract and associated article metadata. Where the abstract did not report specific experimental details or numerical outcomes, those particulars were not reported in the source abstract and should be sought in the full manuscript.